Cellectis Q4 2023 GAAP EPS $(0.64) Misses $(0.26) Estimate, Sales $1.990M Miss $16.263M Estimate

Cellectis SA Sponsored ADR -3.23%

Cellectis SA Sponsored ADR

CLLS

2.10

-3.23%

Cellectis (NASDAQ: CLLS) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.26) by 146.15 percent. The company reported quarterly sales of $1.990 million which missed the analyst consensus estimate of $16.263 million by 87.76 percent. This is a 88.51 percent decrease over sales of $17.322 million the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via